메뉴 건너뛰기




Volumn 56, Issue 1, 2007, Pages 17-23

Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer

Author keywords

Dopamine; Lung cancer; Polymorphism; Receptor; SNP; Transporter

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER;

EID: 33847679017     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.11.007     Document Type: Article
Times cited : (37)

References (26)
  • 1
    • 22144494663 scopus 로고    scopus 로고
    • Molecular epidemiology of non-small cell lung cancer
    • Liu G., Zhou W., and Christiani D.C. Molecular epidemiology of non-small cell lung cancer. Semin Respir Crit Care Med 26 (2005) 265-272
    • (2005) Semin Respir Crit Care Med , vol.26 , pp. 265-272
    • Liu, G.1    Zhou, W.2    Christiani, D.C.3
  • 2
    • 0031879906 scopus 로고    scopus 로고
    • Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians
    • Shields P.G., Lerman C., Audrain J., et al. Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 7 (1998) 453-458
    • (1998) Cancer Epidemiol Biomarkers Prev , vol.7 , pp. 453-458
    • Shields, P.G.1    Lerman, C.2    Audrain, J.3
  • 3
    • 0032481666 scopus 로고    scopus 로고
    • Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients
    • Spitz M.R., Shi H., Yang F., et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 90 (1998) 358-363
    • (1998) J Natl Cancer Inst , vol.90 , pp. 358-363
    • Spitz, M.R.1    Shi, H.2    Yang, F.3
  • 4
    • 33644664300 scopus 로고    scopus 로고
    • Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation
    • Ferone D., Arvigo M., Semino C., et al. Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation. Am J Physiol Endocrinol Metab 289 (2005) E1044-E1050
    • (2005) Am J Physiol Endocrinol Metab , vol.289
    • Ferone, D.1    Arvigo, M.2    Semino, C.3
  • 8
    • 0242329749 scopus 로고    scopus 로고
    • D2s dopamine receptor mediates phospholipase D and antiproliferation
    • Senogles S.E. D2s dopamine receptor mediates phospholipase D and antiproliferation. Mol Cell Endocrinol 209 (2003) 61-69
    • (2003) Mol Cell Endocrinol , vol.209 , pp. 61-69
    • Senogles, S.E.1
  • 9
    • 0036717151 scopus 로고    scopus 로고
    • Reduced tumour growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system
    • Teunis M.A., Kavelaars A., Voest E., et al. Reduced tumour growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system. FASEB J 16 (2002) 1465-1467
    • (2002) FASEB J , vol.16 , pp. 1465-1467
    • Teunis, M.A.1    Kavelaars, A.2    Voest, E.3
  • 10
    • 0032965290 scopus 로고    scopus 로고
    • Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue
    • Basu S., and Dasgupta P.S. Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue. Dig Dis Sci 44 (1999) 916-921
    • (1999) Dig Dis Sci , vol.44 , pp. 916-921
    • Basu, S.1    Dasgupta, P.S.2
  • 11
    • 4143067127 scopus 로고    scopus 로고
    • Ablation of peripheral dopaminergic nerves stimulates malignant tumour growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis
    • Basu S., Sarkar C., Chakroborty D., et al. Ablation of peripheral dopaminergic nerves stimulates malignant tumour growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis. Cancer Res 64 (2004) 5551-5555
    • (2004) Cancer Res , vol.64 , pp. 5551-5555
    • Basu, S.1    Sarkar, C.2    Chakroborty, D.3
  • 12
    • 33644870366 scopus 로고    scopus 로고
    • Polymorphisms of DNA repair genes and risk of non-small cell lung cancer
    • Zienolddiny S., Campa D., Lind H., et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27 (2006) 560-567
    • (2006) Carcinogenesis , vol.27 , pp. 560-567
    • Zienolddiny, S.1    Campa, D.2    Lind, H.3
  • 13
    • 0242691208 scopus 로고    scopus 로고
    • A comparison of bayesian methods for haplotype reconstruction from population genotype data
    • Stephens M., and Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 (2003) 1162-1169
    • (2003) Am J Hum Genet , vol.73 , pp. 1162-1169
    • Stephens, M.1    Donnelly, P.2
  • 14
    • 0030933979 scopus 로고    scopus 로고
    • A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia
    • Arinami T., Gao M., Hamaguchi H., and Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 6 (1997) 577-582
    • (1997) Hum Mol Genet , vol.6 , pp. 577-582
    • Arinami, T.1    Gao, M.2    Hamaguchi, H.3    Toru, M.4
  • 15
    • 23044434010 scopus 로고    scopus 로고
    • The dopamine D2 receptor: new surprises from an old friend
    • Bonci A., and Hopf F.W. The dopamine D2 receptor: new surprises from an old friend. Neuron 47 (2005) 335-338
    • (2005) Neuron , vol.47 , pp. 335-338
    • Bonci, A.1    Hopf, F.W.2
  • 16
    • 22244478946 scopus 로고    scopus 로고
    • Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk
    • Gemignani F., Landi S., Moreno V., et al. Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 14 (2005) 1633-1638
    • (2005) Cancer Epidemiol Biomarkers Prev , vol.14 , pp. 1633-1638
    • Gemignani, F.1    Landi, S.2    Moreno, V.3
  • 17
    • 8544279584 scopus 로고    scopus 로고
    • Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism
    • Finckh U., Rommelspacher H., Kuhn S., et al. Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics 7 (1997) 271-281
    • (1997) Pharmacogenetics , vol.7 , pp. 271-281
    • Finckh, U.1    Rommelspacher, H.2    Kuhn, S.3
  • 18
    • 0033626548 scopus 로고    scopus 로고
    • D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study
    • Wu X., Hudmon K.S., Detry M.A., Chamberlain R.M., and Spitz M.R. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev 9 (2000) 1021-1026
    • (2000) Cancer Epidemiol Biomarkers Prev , vol.9 , pp. 1021-1026
    • Wu, X.1    Hudmon, K.S.2    Detry, M.A.3    Chamberlain, R.M.4    Spitz, M.R.5
  • 19
    • 0031752522 scopus 로고    scopus 로고
    • The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers
    • Pohjalainen T., Rinne J.O., Nagren K., et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3 (1998) 256-260
    • (1998) Mol Psychiatry , vol.3 , pp. 256-260
    • Pohjalainen, T.1    Rinne, J.O.2    Nagren, K.3
  • 20
    • 0033542110 scopus 로고    scopus 로고
    • A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia
    • Okuyama Y., Ishiguro H., Toru M., and Arinami T. A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem Biophys Res Commun 258 (1999) 292-295
    • (1999) Biochem Biophys Res Commun , vol.258 , pp. 292-295
    • Okuyama, Y.1    Ishiguro, H.2    Toru, M.3    Arinami, T.4
  • 21
    • 23444458557 scopus 로고    scopus 로고
    • Dopamine transporter (SLC6A3) 5′ region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease
    • Kelada S.N., Costa-Mallen P., Checkoway H., et al. Dopamine transporter (SLC6A3) 5′ region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease. Pharmacogenet Genomics 15 (2005) 659-668
    • (2005) Pharmacogenet Genomics , vol.15 , pp. 659-668
    • Kelada, S.N.1    Costa-Mallen, P.2    Checkoway, H.3
  • 22
    • 3042734848 scopus 로고    scopus 로고
    • Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis
    • Chakroborty D., Sarkar C., Mitra R.B., Banerjee S., Dasgupta P.S., and Basu S. Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis. Clin Cancer Res 10 (2004) 4349-4356
    • (2004) Clin Cancer Res , vol.10 , pp. 4349-4356
    • Chakroborty, D.1    Sarkar, C.2    Mitra, R.B.3    Banerjee, S.4    Dasgupta, P.S.5    Basu, S.6
  • 23
    • 14744294101 scopus 로고    scopus 로고
    • Dopamine inhibits cell growth and cell cycle by blocking ribonucleotide reductase
    • Woldman I., Reither H., Kattinger A., Hornykiewicz O., and Pifl C. Dopamine inhibits cell growth and cell cycle by blocking ribonucleotide reductase. Neuropharmacology 48 (2005) 525-537
    • (2005) Neuropharmacology , vol.48 , pp. 525-537
    • Woldman, I.1    Reither, H.2    Kattinger, A.3    Hornykiewicz, O.4    Pifl, C.5
  • 24
    • 0041430890 scopus 로고    scopus 로고
    • Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumour cells
    • An J.J., Cho S.R., Jeong D.W., Park K.W., Ahn Y.S., and Baik J.H. Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumour cells. Mol Cell Endocrinol 206 (2003) 49-62
    • (2003) Mol Cell Endocrinol , vol.206 , pp. 49-62
    • An, J.J.1    Cho, S.R.2    Jeong, D.W.3    Park, K.W.4    Ahn, Y.S.5    Baik, J.H.6
  • 25
    • 0035725833 scopus 로고    scopus 로고
    • Dopamine induces phenotypic differentiation or apoptosis in a dose-dependent fashion: involvement of the dopamine transporter and p53
    • Porat S., Premkumar A., and Simantov R. Dopamine induces phenotypic differentiation or apoptosis in a dose-dependent fashion: involvement of the dopamine transporter and p53. Dev Neurosci 23 (2001) 432-440
    • (2001) Dev Neurosci , vol.23 , pp. 432-440
    • Porat, S.1    Premkumar, A.2    Simantov, R.3
  • 26
    • 0035026748 scopus 로고    scopus 로고
    • The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor
    • Basu S., Nagy J.A., Pal S., et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 7 (2001) 569-574
    • (2001) Nat Med , vol.7 , pp. 569-574
    • Basu, S.1    Nagy, J.A.2    Pal, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.